Parkinson's Disease (PD) is a complex, progressive neurodegenerative disorder that primarily affects the motor system. With an increasing prevalence due to an aging population, it is crucial for healthcare professionals to have a comprehensive understanding of this multifaceted condition.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a dopamine deficit in the striatum. This neurodegeneration is accompanied by the presence of Lewy bodies, abnormal aggregates of the protein alpha-synuclein. The exact triggers for these pathological processes remain elusive.
PD typically presents with motor symptoms such as resting tremor, bradykinesia, rigidity, and postural instability. Non-motor symptoms like autonomic dysfunction, neuropsychiatric disturbances, and sensory abnormalities can also occur and significantly impact patients' quality of life.
PD is primarily a clinical diagnosis based on history and physical examination. Neuroimaging techniques and biomarkers are currently under investigation to aid in early diagnosis and differentiate PD from other parkinsonian syndromes.
Management of PD is multidimensional, involving pharmacologic therapies, physical and occupational therapy, and surgical interventions in advanced cases. The mainstay of pharmacologic treatment is dopamine replacement with levodopa. However, the management should be individualized, considering the patient's symptomatology, age, comorbidities, and potential side effects.
PD is a complex disorder with a variable clinical presentation and course. A comprehensive understanding of its pathophysiology, clinical features, diagnostic approach, and management strategies is essential for healthcare professionals to provide optimal care. Ongoing research promises new insights into disease mechanisms and potential therapeutic targets, underscoring the importance of staying updated in this rapidly evolving field.
1.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
4.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
2.
Screening for Cancer-Related Neuromuscular Weakness: Clinical Approaches and Evidence-Based Strategies
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation